An overview of molecular basis of iron metabolism regulation and the associated pathologies

被引:241
作者
Silva, Bruno [1 ]
Faustino, Paula [1 ]
机构
[1] Inst Nacl Saude Dr Ricardo Jorge, Dept Genet Humana, P-1649016 Lisbon, Portugal
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2015年 / 1852卷 / 07期
关键词
Iron; Hepcidin; Post-transcriptional regulation; Hemochromatosis; Iron deficiency; HYPOXIA-INDUCIBLE FACTORS; TRANSFERRIN-BOUND IRON; HEPCIDIN EXPRESSION; GENE-EXPRESSION; RESPONSIVE ELEMENT; MESSENGER-RNA; TRANSCRIPTIONAL ACTIVATION; MATRIPTASE-2; TMPRSS6; FERRITIN DEGRADATION; DEPENDENT REGULATION;
D O I
10.1016/j.bbadis.2015.03.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron is essential for several vital biological processes. Its deficiency or overload drives to the development of several pathologies. To maintain iron homeostasis, the organism controls the dietary iron absorption by enterocytes, its recycling by macrophages and storage in hepatocytes. These processes are mainly controlled by hepcidin, a liver-derived hormone which synthesis is regulated by iron levels, inflammation, infection, anemia and erythropoiesis. Besides the systemic regulation of iron metabolism mediated by hepcidin, cellular regulatory processes also occur. Cells are able to regulate themselves the expression of the iron metabolism-related genes through different post-transcriptional mechanisms, such as the alternative splicing, microRNAs, the IRP/IRE system and the proteolytic cleavage. Whenever those mechanisms are disturbed, due to genetic or environmental factors, iron homeostasis is disrupted and iron related pathologies may arise. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1347 / 1359
页数:13
相关论文
共 195 条
[1]   Hemochromatosis and iron-overload screening in a racially diverse population [J].
Adams, PC ;
Reboussin, DM ;
Barton, JC ;
McLaren, CE ;
Eckfeldt, JH ;
McLaren, GD ;
Dawkins, FW ;
Acton, RT ;
Harris, EL ;
Gordeuk, VR ;
Leiendecker-Foster, C ;
Speechley, M ;
Snively, BM ;
Holup, JL ;
Thomson, E ;
Sholinsky, P ;
Acton, RT ;
Barton, JC ;
Dixon, D ;
Rivers, CA ;
Tucker, D ;
Ware, JC ;
McLaren, CE ;
McLaren, GD ;
Anton-Culver, H ;
Baca, JA ;
Bent, TC ;
Brunner, LC ;
Dao, MM ;
Jorgensen, KS ;
Kuniyoshi, J ;
Le, HD ;
Masatsugu, MK ;
Meyskens, FL ;
Morohashi, D ;
Nguyen, HP ;
Panagon, SN ;
Phung, C ;
Raymundo, V ;
Ton, T ;
Walker, AP ;
Wenzel, LB ;
Ziogas, A ;
Adams, PC ;
Bloch, E ;
Chakrabarti, S ;
Fleischhauer, A ;
Harrison, H ;
Jia, K ;
Larson, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1769-1778
[2]   The hereditary hyperferritinemia-cataract syndrome: a family study [J].
Alvarez-Coca-Gonzalez, Javier ;
Moreno-Carralero, Maria-Isabel ;
Martinez-Perez, Jorge ;
Mendez, Manuel ;
Garcia-Ros, Marta ;
Moran-Jimenez, Maria-Josefa .
EUROPEAN JOURNAL OF PEDIATRICS, 2010, 169 (12) :1553-1555
[3]   microRNAs: Tiny regulators with great potential [J].
Ambros, V .
CELL, 2001, 107 (07) :823-826
[4]   Mammalian iron metabolism and its control by iron regulatory proteins [J].
Anderson, Cole P. ;
Shen, Macy ;
Eisenstein, Richard S. ;
Leibold, Elizabeth A. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (09) :1468-1483
[5]   Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells [J].
Andolfo, Immacolata ;
De Falco, Luigia ;
Asci, Roberta ;
Russo, Roberta ;
Colucci, Simona ;
Gorrese, Marisa ;
Zollo, Massimo ;
Iolascon, Achille .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08) :1244-1252
[6]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[7]  
Andrews PA, 2000, NEW ENGL J MED, V342, P1293
[8]   BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism [J].
Andriopoulos, Billy, Jr. ;
Corradini, Elena ;
Xia, Yin ;
Faasse, Sarah A. ;
Chen, Shanzhuo ;
Grgurevic, Lovorka ;
Knutson, Mitchell D. ;
Pietrangelo, Antonello ;
Vukicevic, Slobodan ;
Lin, Herbert Y. ;
Babitt, Jodie L. .
NATURE GENETICS, 2009, 41 (04) :482-487
[9]   Trasferrin receptor 2 gene regulation by microRNA 221 in SH-SY5Y cells treated with MPP+ as Parkinson's disease cellular model [J].
Asci, Roberta ;
Vallefuoco, Fara ;
Andolfo, Immacolata ;
Bruno, Mariasole ;
De Falco, Luigia ;
Iolascon, Achille .
NEUROSCIENCE RESEARCH, 2013, 77 (03) :121-127
[10]   Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin [J].
Ashby, Damien R. ;
Gale, Daniel P. ;
Busbridge, Mark ;
Murphy, Kevin G. ;
Duncan, Neill D. ;
Cairns, Tom D. ;
Taube, David H. ;
Bloom, Stephen R. ;
Tam, Frederick W. K. ;
Chapman, Richard ;
Maxwell, Patrick H. ;
Choi, Peter .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03) :505-508